4//SEC Filing
Glicklich Alan 4
Accession 0001209191-21-041646
CIK 0001435049other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:40 PM ET
Size
9.4 KB
Accession
0001209191-21-041646
Insider Transaction Report
Form 4
Glicklich Alan
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-06-16$0.42/sh+20,000$8,400→ 20,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-16−20,000→ 222,662 totalExercise: $0.42Exp: 2030-04-21→ Common Stock (20,000 underlying) - Sale
Common Stock
2021-06-16$16.35/sh−20,000$326,968→ 0 total
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.17 to $16.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F3]The stock option vested as to 25% of the total shares on April 20, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Documents
Issuer
CHINOOK THERAPEUTICS, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001823197
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 6:40 PM ET
- Size
- 9.4 KB